Medicare Enrolled
Dr. Christopher Pace, MD
Urology Physician · Grapevine, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pace from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pace?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pace
Dr. Christopher Pace is an urology physician in Grapevine, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Pace performed 2,100 Medicare services across 1,627 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pace received a total of $3,392 from 41 pharmaceutical and/or device companies across 145 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pace is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 47% volume in TX
$3,392 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,100
Medicare services
Top 47% in TX for urology physician
1,627
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~105 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
423 | $2 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
383 | $87 | $281 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
243 | $8 | $24 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
147 | $115 | $360 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
85 | $7 | $14 |
| PSA test (prostate cancer screening) | 83 | $18 | $41 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
69 | $69 | $314 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
49 | $18 | $51 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
48 | $61 | $164 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
46 | $34 | $355 |
| Herpes simplex virus nucleic acid test A laboratory test that uses an amplified probe technique to detect the genetic material of the herpes simplex virus. |
46 | $34 | $197 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
46 | $34 | $117 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
40 | $65 | $210 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
36 | $18 | $41 |
| Online digital E/M service, established patient, 11-20 min An online digital evaluation and management service for an established patient. The service involves a total time of 11 to 20 minutes over a period of up to 7 days. |
29 | $20 | $61 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
28 | $119 | $1,113 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
23 | $179 | $523 |
| CMV nucleic acid detection test A laboratory test that uses amplified probe techniques to detect cytomegalovirus (CMV) genetic material in a sample. |
23 | $34 | $78 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
23 | $34 | $78 |
| Herpes virus-6 nucleic acid test A laboratory test that uses amplified probe techniques to detect the genetic material of herpes virus-6. |
23 | $34 | $78 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
23 | $34 | $78 |
| Strep A nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present. |
23 | $34 | $78 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
23 | $34 | $78 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
22 | $136 | $391 |
| Online digital evaluation for established patient, 5-10 minutes This service involves an online digital evaluation and management visit for an established patient. It covers a total time of 5 to 10 minutes over a period of up to 7 days. |
22 | $11 | $31 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
18 | $25 | $57 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
18 | $102 | $289 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
17 | $3 | $8 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
16 | $67 | $242 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
13 | $132 | $405 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
12 | $19 | $164 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.3% high complexity
12.1% medium
86.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,392
Total received (2018-2024)
Avg $485/year across 7 years
Top 48% in TX for urology physician
41
Companies
145
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,182 (93.8%)
Scientific / Research
Research funding and grants
$210 (6.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$777
2023
$710
2022
$476
2021
$341
2020
$263
2019
$416
2018
$410
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$408
ABBVIE INC.
$316
PFIZER INC.
$310
Boston Scientific Corporation
$273
Janssen Biotech, Inc.
$211
Axonics, Inc.
$165
BOSTON SCIENTIFIC CORPORATION
$127
Coloplast Corp
$122
Blue Earth Diagnostics Limited
$118
Olympus America Inc.
$100
Endo Pharmaceuticals Inc.
$99
ACCORD HEALTHCARE, INC.
$95
Endo USA, Inc.
$88
Sumitomo Pharma America, Inc.
$83
Merck Sharp & Dohme LLC
$71
Janssen Scientific Affairs, LLC
$70
COLOPLAST CORP
$64
UroGen Pharma, Inc.
$63
Ferring Pharmaceuticals Inc.
$61
MEDIVATION FIELD SOLUTIONS LLC
$59
UROGEN PHARMA, INC.
$44
AbbVie Inc.
$36
TherapeuticsMD, Inc.
$36
AbbVie, Inc.
$36
Kowa Pharmaceuticals America, Inc.
$34
Antares Pharma, Inc.
$31
Verity Pharmaceuticals Inc.
$27
PROGENICS PHARMACEUTICALS, INC.
$25
Accord Healthcare, Inc.
$22
Bayer HealthCare Pharmaceuticals Inc.
$20
Myovant Sciences Inc.
$20
Progenics Pharmaceuticals, Inc.
$20
Biocomposites Inc
$19
Avadel Specialty Pharmaceuticals, LLC
$18
Supernus Pharmaceuticals, Inc.
$18
Amgen Inc.
$16
TOLMAR Pharmaceuticals, Inc.
$15
Tolmar, Inc.
$14
GENZYME CORPORATION
$14
ACELL, INC.
$12
180 Medical, Inc.
$11
Top 3 companies account for 30.4% of total payments
Associated products mentioned in payments ›
ANNOVERA · AVEED · Axonics · Axumin · BOTOX · Bulkamid · CAMCEVI · Coloplast TFL Drive · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL BPH · GENERAL BPH · GENTLECATH · General - Therapies · Isiris · Isiris aStent Removal Device · JELMYTO · JEVTANA · KEYTRUDA · Kyleena · LO LOESTRIN FE · LUPRON DEPOT · LYNPARZA · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · ORGOVYX · POSLUMA · PYLARIFY · Prolia · ReTrace · Rezum Generator · SEGLENTIS · Stenostent · Stimulan · Trelstar · URETERO-RENO FIBERSCOPE · VESICARE · Veozah · XIAFLEX · XTANDI · XYOSTED · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $162 per 100 Medicare services performed
Geographic Context
Urology physicians within 10 mi
180
Per 100K population
8.4
County median income
$81,905
Nearest hospital
BAYLOR SCOTT & WHITE MEDICAL CENTER GRAPEVINE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Pace is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Pace experienced with automated urinalysis?
Based on Medicare claims data, Dr. Pace performed 423 automated urinalysis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pace receive payments from pharmaceutical companies?
Yes. Dr. Pace received a total of $3,392 from 41 companies across 145 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pace's costs compare to other urology physicians in Grapevine?
Dr. Pace's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pace) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Grapevine
Browse urology physicians in Grapevine ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology